You are viewing an incomplete version of our website. Please click to reload the website as full version.

ATF2 antibody (Activating Transcription Factor 2) (pThr55)

Details for Product anti-ATF2 Antibody No. ABIN965609, Supplier: Log in to see
Antigen
  • CHN1
  • CG12850
  • CG3749
  • dATF-2
  • DmelCG30420
  • CG30420
  • CRE-BP1
  • CREB2
  • HB16
  • TREB7
  • Atf-2
  • CRE-BP
  • Creb2
  • D130078H02Rik
  • D18875
  • Tg(Gzma-Klra1)7Wum
  • mXBP
  • atf2-A
  • atf2l
  • ATF1
  • ATF2
  • HFB1-GDNF
  • HSCR3
Alternatives
anti-Human ATF2 antibody for Western Blotting
Epitope
pThr55, pThr73
54
46
41
34
34
32
31
30
26
25
24
23
18
17
13
13
12
12
10
9
9
9
8
7
7
7
6
6
6
5
5
5
5
5
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine), Rat (Rattus)
571
327
298
20
10
6
5
4
2
2
2
1
1
1
1
Host
Rabbit
523
32
15
4
Conjugate
This ATF2 antibody is un-conjugated
15
15
15
14
9
9
9
9
9
9
9
9
6
6
6
Application
Immunohistochemistry (IHC)
380
244
152
105
85
85
82
22
10
8
7
3
2
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen The antiserum was produced against synthesized phosphopeptide derived from human ATF-2 around the phosphorylation site of threonine 73 or 55 (D-L-SP-P-L).
Specificity ATF-2 (phospho-Thr73 or 55) antibody detects endogenous levels of ATF-2 only when phosphorylated at threonine 73 or 55.
Alternative Name ATF2 (ATF2 Antibody Abstract)
Research Area Immunology, Innate Immunity, Transcription Factors
Pathways MAPK Signaling, RTK Signaling, TCR Signaling
Application Notes IHC: 1:50-1:100.
Restrictions For Research Use only
Format Liquid
Concentration 100ug/100ul.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Background publications Beausoleil, Jedrychowski, Schwartz et al.: "Large-scale characterization of HeLa cell nuclear phosphoproteins." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 33, pp. 12130-5, 2004 (PubMed).

Gupta, Campbell, Dérijard et al.: "Transcription factor ATF2 regulation by the JNK signal transduction pathway." in: Science (New York, N.Y.), Vol. 267, Issue 5196, pp. 389-93, 1995 (PubMed).

van Dam, Wilhelm, Herr et al.: "ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents." in: The EMBO journal, Vol. 14, Issue 8, pp. 1798-811, 1995 (PubMed).

Livingstone, Patel, Jones: "ATF-2 contains a phosphorylation-dependent transcriptional activation domain." in: The EMBO journal, Vol. 14, Issue 8, pp. 1785-97, 1995 (PubMed).

Abdel-Hafiz, Heasley, Kyriakis et al.: "Activating transcription factor-2 DNA-binding activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinases." in: Molecular endocrinology (Baltimore, Md.), Vol. 6, Issue 12, pp. 2079-89, 1993 (PubMed).